Active-site conformation of 17-(3-pyridyl)androsta-5,16-dien-3β-ol, a potent inhibitor of the P450 enzyme C17α-hydroxylase/C17-20 lyase
✍ Scribed by David F. Burke; Charles A. Laughton; Chris F. Snook; Stephen Neidle; Gerard A. Potter; Michael Jarman
- Publisher
- Elsevier Science
- Year
- 1995
- Tongue
- English
- Weight
- 228 KB
- Volume
- 5
- Category
- Article
- ISSN
- 0960-894X
No coin nor oath required. For personal study only.
✦ Synopsis
17-(3-pyridyl)androsta-5,16-dien-3[~-ol, a nanomolar inhibitor of the P450 enzyme C17ct-hydroxylase/C17-20 lyase, is a target for prostate cancer chemotherapy. A model is presented for the inhibitor docked into the structure of the enzyme.
📜 SIMILAR VOLUMES
The 16,17-Double Bond Is Needed for Irreversible Inhibition of Human Cytochrome P450 17α by Abiraterone (17-(3-Pyridyl)androsta-5,16-dien-3β-ol) and Related Steroidal Inhibitors. -Investigation of the structural features required for irreversible binding of steroidal inhibitors, e.g. (I)-(VI), to th